3528 results for «2025-12-19至2026-01-05+智光电气+异动分析»

Filter By

3528 results

Positive 3-year results from FIRE Trial demonstrate Supraflex Cruz’s safety and efficacy in elderly heart attack patients

26 Sep 2025

SMT’s Hydra TAVR Valve demonstrates sustained safety, durability, and hemodynamic performance at 5 Years

19 Nov 2025

PCR Seminars 2024: education brought to your doorstep!

Foldax announces positive one-year data on TRIA Mitral Valve

27 Jun 2025

Pi-Cardia’s ShortCut™ Becomes First Leaflet Modification Technology to Receive CMS NTAP for Valve-in-Valve TAVR

06 Aug 2025

Jupiter Endovascular closes oversubscribed Series B Financing, surpassing $40 million target

07 Oct 2025

FFR or 3d-quantitative coronary angiography-based vessel-FFR guided revascularisation – The FAST III trial

28 Mar 2026

Chiara De Biase provides her take on the FAST III Trial presented by Joost Daemen at ACC.26 in New Orleans. She reviews the comparison between vFFR and FFR, highlighting key findings and their impact on revascularisation strategies.

Author

Chiara De Biase
FAST III: FFR vs 3D-QCA vessel-guided revascularisation

Bentley acquired the GoBack catheter

13 Sep 2022

How to perform ELASTA-Clip: lacerating M-TEER devices to enable TMVR

09 Mar 2026

Recurrent mitral regurgitation after M-TEER can create a challenging scenario. Discover the ELASTA-Clip technique and its key steps to enable TMVR!

Jonathan Curio

Author

Jonathan Curio

Author

Matti Adam
How to perform ELASTA-Clip: lacerating M-TEER devices to enable TMVR

Fondazione Ricerca e Innovazione Cardiovascolare completes enrollment in TRANSFORM II RCT, a landmark study comparing MagicTouch SCB vs DES in native coronary vessels

12 Jun 2025

SMT Announces Completion of Patient Enrolment for TUXEDO-2 Trial

16 Aug 2024

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

01 Apr 2025

Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.

Yohei Ohno

Author

Yohei Ohno
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

Quadruple pulmonary vein stenting for post-ablation stenosis

28 Apr 2025

Watch this EuroIntervention image to discover how a complex case of severe pulmonary vein stenosis after atrial fibrillation ablation was successfully managed with multi-stent implantation and intravascular imaging guidance — restoring the patient’s quality of life almost immediately.

Quadruple pulmonary vein stenting for post-ablation stenosis

Elixir Medical announces launch of LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Europe

09 Apr 2025

BIOSOLVE-IV full-cohort two-year data confirm excellent safety and efficacy profile of Magmaris resorbable magnesium scaffold

23 Sep 2022

First patient enrolled in Erectile Dysfunction prospective randomized study with SELUTION SLR

09 Sep 2022

Prompt intervention for severe aortic stenosis patients demonstrates lower healthcare costs, improved clinical outcomes

22 May 2025

Cardiawave announces positive six-month data from valvosoft pivotal study at transcatheter cardiovascular therapeutics (TCT) conference

28 Oct 2024

Atrial flow regulator implantation through atrial septal defect of previous mitral transcatheter edge-to-edge repair: bailout strategy

30 Jun 2025

Mitral transcatheter edge-to-edge repair (M-TEER) has reshaped the prognosis for heart failure patients with secondary mitral regurgitation, but recurrence remains a real challenge when surgical options are off the table.

This case highlights an innovative use of an atrial flow regulator (AFR) to manage elevated left atrial...

Interatrial shunt after mitral transcatheter edge-to-edge repair

Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3

02 Apr 2025

Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
FFR-guided PCI vs CABG: 5-year results of the FAME 3 trial
Didn’t find what you were looking for?